Skip to content
healthcare.dev
Get a free key

NP Thyroid

NDC 17224-504, Thyroid tablets, tablet, from Calvin Scott & Co Inc..

Product NDC
17224-504
Status
Listed
Labeler
Calvin Scott & Co Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED DRUG OTHER
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/17224-504 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LIOTHYRONINE13.5 ug/1
  • LEVOTHYROXINE57 ug/1

Pharmacologic classes

Thyroxine [CS]; Triiodothyronine [CS]; l-Thyroxine [EPC]; l-Triiodothyronine [EPC]

Package NDCNDC-11Package
17224-504-281722405042828 TABLET in 1 BOTTLE (17224-504-28)
17224-504-301722405043030 TABLET in 1 BOTTLE (17224-504-30)
17224-504-601722405046060 TABLET in 1 BOTTLE (17224-504-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 17224-504 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/17224-504 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 17224-504. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.